Replies to post #50775 on Sunshine Biopharma Inc (SBFM)

[GMJDubbs]

No no, it was a fluff info site. Barely covered anything. Hence why they probably took it down. Only made through Wix too. It’s what a company does to disconnect from being a non profit status or affiliation, and be taken seriously as a business not some University Lab Organization.

[StockRoomBully]

LAST NEWS RELEASE showed .COM

For Immediate Release
June 1, 2020
SUNSHINE BIOPHARMA FILES A PATENT APPLICATION FOR A NEW
CORONAVIRUS COVID-19 TREATMENT
Montreal, Canada – (ACCESSWIRE) –

Sunshine Biopharma Inc.

(OTC Pink Sheets: “SBFM”), a
pharmaceutical company focused on the research, development and commercialization of drugs
for the treatment of aggressive forms of cancer today announced that it has filed a patent
application in the United States for a new treatment for Coronavirus infections, including
COVID-19. Sunshine’s patent application covers composition subject matter pertaining to small
molecules for inhibition of the main Coronavirus protease (Mpro), an enzyme that is essential for
viral replication. The small molecules covered by the patent application were computer modelled
and designed by Dr. Steve N. Slilaty, CEO of Sunshine Biopharma. The patent application has
a priority date of May 22, 2020.
“The causative agent of the current COVID-19 global pandemic is Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), one of several strains of Coronavirus capable of
infecting humans and causing serious illness. SARS-CoV-2 produces several functional proteins
in infected human cells by cleaving them from two overlapping viral ‘polyproteins,’ pp1a and
pp1ab. One of these functional proteins is a cysteine protease referred to as the main protease
(Mpro, also called 3CLpro and nsp5). Mpro cleaves the viral ‘polyproteins’ at a number of
specific sites thereby generating a multi-subunit protein complex termed ‘viral replicase-
transcriptase’. Because of its functional indispensability in viral replication, Mpro is an attractive
drug target for the development of a treatment for COVID-19 and other Coronavirus infections,”
said Dr. Slilaty.